Back to Agendas
The Use of Adaptive and Bayesian Approaches in Clinical Trials: Sharing Experiences and Case Studies
Session Chair(s)
Joan Buenconsejo, PhD, MPH
Head of Cardiovascular and Neuroscience Biostatistics
Bristol Myers Squibb, United States
The use of adaptive designs and Bayesian approaches in clinical development for new drug products has gained momentum in recent years, with the applications in both the learning and confirmatory phases of development. In this forum, the panel will share their experience with the use of adaptive designs and Bayesian approaches in clinical development. Some of what will be presented is based on work by the members of the DIA Scientific Working Group.
This forum has been developed by the DIA Adaptive and the Bayesian Scientific Working Groups.
Learning Objective : Discuss recent research exploring the observation that many clinical trials are too complex; Provide a framework for the design of focused clinical trials that cut through the unnecessary baggage and efficiently focus on the trial objectives; Describe how collaboration of the adaptive and Bayesian scientific working groups has been fostered among industry, academia and government.
Speaker(s)
Adaptive Design Case Study
Joan Buenconsejo, PhD, MPH
Bristol Myers Squibb, United States
Head of Cardiovascular and Neuroscience Biostatistics
Addressing Challenges and Opportunities of "Less Well Understood" Adaptive Designs
Weili He, PhD
AbbVie, United States
Senior Director, Head of Global Medical Affairs Statistics
Exploring Bayesian Approaches in Drug Clinical Trials
Freda Cooner, PhD
Eli Lilly and Company, United States
Senior Director - Statistics
Panelist
Estelle Russek-Cohen, PhD
FDA, United States
Senior Advisor, Office of Biostat
Have an account?